Affinity Asset Advisors »

Voyager Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $303k 52k 5.85

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Verona Pharma Sponsored Ads (VRNA)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nuvalent Inc-a (NUVL)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Vera Therapeutics Cl A (VERA)
Nurix Therapeutics (NRIX)

View all positions for Affinity Asset Advisors

Top funds holding Voyager Therapeutics

Armistice Capital
BlackRock
EcoR1 Capital
Vanguard Group
Farallon Capital Management
Dimensional Fund Advisors
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
T. Rowe Price Associates
Dr. Jeffrey R. Jay, M.D.
Vestal Point Capital
Morgan Stanley
Northern Trust
Prudential Financial

View all funds holding Voyager Therapeutics